XWELL Inc (XWEL)
1.71
-0.07
(-3.93%)
USD |
NASDAQ |
May 01, 16:00
1.73
+0.02
(+1.17%)
Pre-Market: 20:00
XWELL Cash from Financing (TTM): 0.008M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.008M |
September 30, 2023 | 0.287M |
June 30, 2023 | -10.99M |
March 31, 2023 | -13.46M |
December 31, 2022 | -27.38M |
September 30, 2022 | -37.08M |
June 30, 2022 | -27.39M |
March 31, 2022 | -24.93M |
December 31, 2021 | 6.35M |
September 30, 2021 | 52.64M |
June 30, 2021 | 85.54M |
March 31, 2021 | 128.78M |
December 31, 2020 | 117.22M |
September 30, 2020 | 80.00M |
June 30, 2020 | 50.51M |
March 31, 2020 | 7.116M |
December 31, 2019 | 1.165M |
September 30, 2019 | 4.404M |
June 30, 2019 | 2.214M |
March 31, 2019 | 5.698M |
December 31, 2018 | 5.644M |
September 30, 2018 | 2.722M |
June 30, 2018 | 9.325M |
March 31, 2018 | 6.228M |
December 31, 2017 | 6.087M |
Date | Value |
---|---|
September 30, 2017 | 4.396M |
June 30, 2017 | -2.272M |
March 31, 2017 | -2.372M |
December 31, 2016 | -2.061M |
September 30, 2016 | -0.937M |
June 30, 2016 | -0.66M |
March 31, 2016 | 11.55M |
December 31, 2015 | 11.60M |
September 30, 2015 | 12.21M |
June 30, 2015 | 12.21M |
March 31, 2015 | 10.66M |
December 31, 2014 | 13.45M |
September 30, 2014 | 13.48M |
June 30, 2014 | 14.69M |
March 31, 2014 | 4.186M |
December 31, 2013 | 1.564M |
September 30, 2013 | 57.52M |
June 30, 2013 | 86.02M |
March 31, 2013 | 85.87M |
December 31, 2012 | 85.69M |
September 30, 2012 | 30.50M |
June 30, 2012 | 2.229M |
March 31, 2012 | 1.543M |
December 31, 2011 | 1.198M |
September 30, 2011 | 0.084M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-37.08M
Minimum
Sep 2022
128.78M
Maximum
Mar 2021
20.79M
Average
2.214M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Fonar Corp | -8.460M |
ProPhase Labs Inc | 5.757M |
Applied DNA Sciences Inc | -0.0351M |
Veracyte Inc | 2.837M |
OncoCyte Corp | 12.19M |